As cancer therapies grow more powerful and survival rates climb, medicine has uncovered a quiet reckoning: the drugs that defeat tumors can quietly wound the heart. A new discipline — cardio-oncology — has emerged to hold both truths at once, insisting that surviving cancer must not come at the cost of the organ that sustains life itself. This is the story of medicine learning to protect what it once overlooked, and of patients who deserve to be cured wholly, not partially.
Cardio-oncologia na prática: protegendo o coração durante o tratamento do câncer
Cobertura Relacionada
Fortaleza realizou mobilização massiva de imunização com 3 mil profissionais em 264 locais, incluindo multivacinação, mu…
Folha de S.Paulo · Aug 23 Tratar apneia do sono pode reduzir pressão arterial em hipertensosEstudo brasileiro demonstra que tratar apneia obstrutiva do sono contribui para reduzir hipertensão resistente, mesmo em…
Rádio Pampa · Aug 23 Duas em cada três pessoas com Alzheimer são mulheres; sintomas podem começar aos 45Pesquisa mostra que duas em cada três pessoas com Alzheimer são mulheres, com sintomas podendo começar aos 45 anos devid…
Rádio Pampa · Aug 23 Dieta rica em vegetais reduz risco de doença renal crônica, aponta estudoEstudo com 179.508 participantes mostra que dieta rica em vegetais, frutas e grãos integrais reduz risco de doença renal…
Impacto Geopolítico
Medical article on cardio-oncology lacks geopolitical significance; focuses on clinical cardiovascular management in cancer patients.
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Lente Económico
Integrated cardio-oncology approach addresses cardiovascular risks from modern cancer therapies, shifting from reactive treatment to proactive monitoring, creating demand for specialized medical services and integrated care models.
Cancer patients face increased healthcare costs and complexity from dual treatment protocols; improved survival rates offset by need for continuous cardiovascular monitoring, potentially increasing out-of-pocket expenses and medical consultations.
Healthcare systems may need to establish integrated cardio-oncology protocols, increase specialist training, adjust reimbursement models for combined cardiology-oncology care, and implement preventive screening guidelines for cancer survivors.